| Describe the opioid prescribing trends inside and outside the Military Health System (MHS). |
|
|
|
|
|
|
|
| Explain how the Defense and Veterans Pain Rating Scale (DVPRS) and Pain Assessment Screening Tool and Outcomes Registry (PASTOR) are utilized as part of the DHA pain management and safe opioid prescribing clinical practices. |
|
|
|
|
|
|
|
| Summarize how the VA-DoD Stepped Care Model (SCM) for Pain Management is used to collaborate with patients to create pain treatment goals that are achievable and relevant to the patient. |
|
|
|
|
|
|
|
| Identify when to refer and connect appropriate patients with chronic and acute pain for cognitive behavioral therapy for pain and other mental health resources for pain management. |
|
|
|
|
|
|
|
| Explain key components of the Opioid Overdose Education and Naloxone Distribution (OEND), including indications for prescribing naloxone and efforts to increase availability to naloxone to patients at risk. |
|
|
|
|
|
|
|
| Identify risk factors and behavioral characteristics associated with prescription medication misuse and Opioid Use Disorder. |
|
|
|
|
|
|
|
| Explain when an active-duty beneficiary's controlled-substance prescription will expire according to DoDI 1010.16. |
|
|
|
|
|
|
|
| List opioid risk mitigation guidelines, tools, and resources for safe prescribing. |
|
|
|
|
|
|
|
| Identify potential Substance Use and Opioid Use Disorders (OUDs) and other mental health comorbidities that occur when managing pain, the available psychotherapies, and Medicine for Opioid Use Disorder (MOUD) available within DoD upon referral. |
|
|
|
|
|
|
|